Autolus Therapeutics Builds Rockville R&D Headquarters

Published 2-24-2019

Autolus Therapeutics has signed a long-term, full-building lease with Alexandria Real Estate Equities for the construction and development of a build-to-suit facility in Rockville, Md. Located in the Shady Grove Life Sciences Center, the 85,000-sf project will accommodate the company's U.S. headquarters and a commercial-scale manufacturing center for cell therapies. Occupancy is expected in 2021. Based in London, Autolus is also initiating a build-out of a biopharmaceutical manufacturing facility in Enfield in the United Kingdom, which is slated for completion in 2020.